Why the study?
Is polycystic ovary syndrome associated with a higher prevalence of metabolic complications and cardiovascular morbidity and mortality in women?
Is polycystic ovary syndrome associated with a higher prevalence of metabolic complications and cardiovascular morbidity and mortality in women?
Answers are grounded in this paper and cite their sources.
PCOS is associated with increased cardiometabolic risk factors such as obesity and dyslipidemia, but longitudinal evidence does not definitively prove an increased risk of hard cardiovascular diseases.
The purpose of this study was to perform a review of the longitudinal studies to determine whether polycystic ovary syndrome is associated with higher prevalence of metabolic complications and cardiovascular morbidity and mortality. The primary outcomes included body mass index, metabolic syndrome and its components (waist circumference, lipid profile, arterial hypertension, abnormal glucose metabolism (impaired fasting glucose, impaired glucose tolerance, type 2 diabetes), insulin resistance, and cardiovascular diseases like stroke, angina, and coronary heart disease. Complications in pregnant women were beyond the scope of this review. PubMed database (1992-2018) was searched to identify proper publications. Finally, data from 47 articles were analysed. Studies differed in the design (prospective, retrospective, cohort, observational), research methods, polycystic ovary syndrome diagnostic criteria, studied populations, race, and ethnicity of the participants. Based on the data collected, it appears that women with polycystic ovary syndrome have higher prevalence of obesity, abdominal fat distribution, dyslipidaemia and deterioration of glucose metabolism, but increased prevalence of cardiovascular diseases is not proven.
No takes yet. Share an insight, caveat, or question.
Jacewicz‐Święcka et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: